At the news
? BEARISHIMPACT 6/10 144 filed May 12, 2026 at 18:13 ET
Co-founder and CEO AmirAli Talasaz filed a Form 144 to sell 260,000 shares of Guardant Health common stock, valued at approximately $26.1 million based on the filing date. This is a material insider sale by the CEO, representing a significant portion of his holdings and signaling potential bearish sentiment ahead of any upcoming catalysts.
- CEO AmirAli Talasaz filed to sell 260,000 shares of GH common stock.
- Estimated sale value: ~$26.1 million based on filing date.
- Shares to be sold through Stifel Nicolaus & Company Inc.
- Sale includes shares acquired via open market purchases, RSUs, stock options, and founder shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access